PECAM1 and chronic obstructive pulmonary disease: According to a study, a potential non-invasive technique to track the evolution of the disease may be the presence of CD31-MPs, CD66b-MPs, and CD235ab-MP in COPD sputum, which may reflect pulmonary endothelial damage and COPD progression [102].